Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.67
-0.49-2.56%
Last update: Jun 24, 4:33 PM
$18.75
-0.41-2.14%
Biodesix Inc Analyst Ratings
BDSXNASDAQ
Biodesix Analyst Ratings and Price Targets | NASDAQ:BDSX | Benzinga
Biodesix Inc has a consensus price target of $9.19 based on the ratings of 8 analysts. The high is $27 issued by Canaccord Genuity on June 18, 2026. The low is $1.5 issued by Craig-Hallum on May 14, 2025. The 3 most-recent analyst ratings were released by Canaccord Genuity, HC Wainwright & Co., and Canaccord Genuity on June 18, 2026, June 15, 2026, and May 5, 2026, respectively. With an average price target of $25 between Canaccord Genuity, HC Wainwright & Co., and Canaccord Genuity, there's an implied 33.33% upside for Biodesix Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Canaccord Genuity
HC Wainwright & Co.
Scotiabank
Craig-Hallum
Lake Street
1calculated from analyst ratings
Analyst Ratings for Biodesix
Loading calendar...
FAQ
What is the target price for Biodesix (BDSX) stock?
The latest price target for Biodesix (NASDAQ:BDSX) was reported by Canaccord Genuity on June 18, 2026. The analyst firm set a price target for $27.00 expecting BDSX to rise to within 12 months (a possible 44.00% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Biodesix (BDSX)?
The latest analyst rating for Biodesix (NASDAQ:BDSX) was provided by Canaccord Genuity, and Biodesix maintained their buy rating.
When was the last upgrade for Biodesix (BDSX)?
The last upgrade for Biodesix Inc happened on February 27, 2026 when William Blair raised their price target to N/A. William Blair previously had a market perform for Biodesix Inc.
When was the last downgrade for Biodesix (BDSX)?
The last downgrade for Biodesix Inc happened on May 14, 2025 when William Blair changed their price target from N/A to N/A for Biodesix Inc.
When is the next analyst rating going to be posted or updated for Biodesix (BDSX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Biodesix, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Biodesix was filed on June 18, 2026 so you should expect the next rating to be made available sometime around June 18, 2027.
Is the Analyst Rating Biodesix (BDSX) correct?
While ratings are subjective and will change, the latest Biodesix (BDSX) rating was a maintained with a price target of $22.00 to $27.00. The current price Biodesix (BDSX) is trading at is $18.75, which is out of the analyst’s predicted range.
